Innovating to improve health worldwide

79th World Health Assembly (WHA79): Follow-up to the political declaration of the high-level meeting of the General Assembly on the prevention and control of non-communicable diseases

On 21 May 2026, IFPMA published a statement on the follow-up to the political declaration of the high-level meeting of the General Assembly on the prevention and control of non-communicable diseases, on the margins of the World Health Assembly. IFPMA welcomes WHO’s continued efforts to tackle one of the greatest health challenges of our lifetimes....

79th World Health Assembly (WHA79): Open-ended Intergovernmental Working Group on the WHO Pandemic Agreement

On 18 May 2026, IFPMA delivered a statement on the Open-Ended Intergovernmental Working Group on the WHO Pandemic Agreement at the 79th World Health Assembly in Geneva. The innovative pharmaceutical industry remains a critical partner in pandemic preparedness and response, with a strong track record of action during pandemics and Public Health Emergencies of International...

Multi-Stakeholder Hearing for the 2026 UN High-Level Meeting on HIV/AIDS

On 14 May 2026 in New York City, IFPMA delivered a statement at the Multi-Stakeholder Hearing ahead of the UN High-Level Meeting on HIV/AIDS. The 2026 High-Level Meeting comes at a sensitive but important moment for the global HIV response. Meaningful progress has been made, but it remains fragile, uneven, and vulnerable to reversal if...

Sixth resumed meeting of the open-ended Intergovernmental Working Group (IGWG 6) on the WHO Pandemic Agreement: PABS instrument

On 30 April 2026, IFPMA delivered a statement at the Sixth resumed meeting of the open-ended Intergovernmental Working Group (IGWG 6) on the WHO Pandemic Agreement.